| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2184365 | Journal of Molecular Biology | 2014 | 10 Pages |
•KM blocks proteasome activity in the presence of SDS.•Cocrystal structure of yeast 20S proteasome and KM shows novel binding mode.•KM binds to the proteasome at an exo-site between subunits β2 and β7′.•Allosteric effect is not observed.•Rapid cytotoxic effect of KM due to polypharmacological mode of action, not proteasome inhibition.
Natural products are a valuable source for novel lead structures in drug discovery, but for the majority of isolated bioactive compounds, the cellular targets are unknown. The structurally unique ansa-polyketide kendomycin (KM) was reported to exert its potent cytotoxic effects via impairment of the ubiquitin proteasome system, but the exact mode of action remained unclear. Here, we present a systematic biochemical characterization of KM–proteasome interactions in vitro and in vivo, including complex structures of wild type and mutant yeast 20S proteasome with KM. Our results provide evidence for a polypharmacological mode of action for KM's cytotoxic effect on cancer cells.
Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (414 K)Download as PowerPoint slide
